287 related articles for article (PubMed ID: 28929814)
1. What's new in the diagnosis of pancreatic cancer: a patent review (2011-present).
Boulaiz H; Ramos MC; Griñán-Lisón C; García-Rubiño ME; Vicente F; Marchal JA
Expert Opin Ther Pat; 2017 Dec; 27(12):1319-1328. PubMed ID: 28929814
[TBL] [Abstract][Full Text] [Related]
2. Early detection of sporadic pancreatic cancer: summative review.
Chari ST; Kelly K; Hollingsworth MA; Thayer SP; Ahlquist DA; Andersen DK; Batra SK; Brentnall TA; Canto M; Cleeter DF; Firpo MA; Gambhir SS; Go VL; Hines OJ; Kenner BJ; Klimstra DS; Lerch MM; Levy MJ; Maitra A; Mulvihill SJ; Petersen GM; Rhim AD; Simeone DM; Srivastava S; Tanaka M; Vinik AI; Wong D
Pancreas; 2015 Jul; 44(5):693-712. PubMed ID: 25931254
[TBL] [Abstract][Full Text] [Related]
3. Early detection of pancreatic cancer: Where are we now and where are we going?
Zhou B; Xu JW; Cheng YG; Gao JY; Hu SY; Wang L; Zhan HX
Int J Cancer; 2017 Jul; 141(2):231-241. PubMed ID: 28240774
[TBL] [Abstract][Full Text] [Related]
4. What's new in treatment of pancreatic cancer: a patent review (2010-2017).
Ramos MC; Boulaiz H; Griñan-Lison C; Marchal JA; Vicente F
Expert Opin Ther Pat; 2017 Nov; 27(11):1251-1266. PubMed ID: 28665163
[TBL] [Abstract][Full Text] [Related]
5. Circulating tumor DNA as a liquid biopsy target for detection of pancreatic cancer.
Takai E; Yachida S
World J Gastroenterol; 2016 Oct; 22(38):8480-8488. PubMed ID: 27784960
[TBL] [Abstract][Full Text] [Related]
6. Improving pancreatic cancer diagnosis using circulating tumor cells: prospects for staging and single-cell analysis.
Court CM; Ankeny JS; Hou S; Tseng HR; Tomlinson JS
Expert Rev Mol Diagn; 2015; 15(11):1491-504. PubMed ID: 26390158
[TBL] [Abstract][Full Text] [Related]
7. Molecular Biomarkers of Pancreatic Intraepithelial Neoplasia and Their Implications in Early Diagnosis and Therapeutic Intervention of Pancreatic Cancer.
Guo J; Xie K; Zheng S
Int J Biol Sci; 2016; 12(3):292-301. PubMed ID: 26929736
[TBL] [Abstract][Full Text] [Related]
8. New developments in the early diagnosis of pancreatic cancer.
Zhang Q; Chen S; Zeng L; Chen Y; Lian G; Qian C; Li J; Xie R; Huang KH
Expert Rev Gastroenterol Hepatol; 2017 Feb; 11(2):149-156. PubMed ID: 27937041
[TBL] [Abstract][Full Text] [Related]
9. Molecular Imaging with MRI: Potential Application in Pancreatic Cancer.
Chen C; Wu CQ; Chen TW; Tang MY; Zhang XM
Biomed Res Int; 2015; 2015():624074. PubMed ID: 26579537
[TBL] [Abstract][Full Text] [Related]
10. Circulating RNAs as new biomarkers for detecting pancreatic cancer.
Kishikawa T; Otsuka M; Ohno M; Yoshikawa T; Takata A; Koike K
World J Gastroenterol; 2015 Jul; 21(28):8527-40. PubMed ID: 26229396
[TBL] [Abstract][Full Text] [Related]
11. Pancreatic cancer early detection: expanding higher-risk group with clinical and metabolomics parameters.
Urayama S
World J Gastroenterol; 2015 Feb; 21(6):1707-17. PubMed ID: 25684935
[TBL] [Abstract][Full Text] [Related]
12. Modelling the benefits of early diagnosis of pancreatic cancer using a biomarker signature.
Ghatnekar O; Andersson R; Svensson M; Persson U; Ringdahl U; Zeilon P; Borrebaeck CA
Int J Cancer; 2013 Nov; 133(10):2392-7. PubMed ID: 23649606
[TBL] [Abstract][Full Text] [Related]
13. Identification of highly sensitive biomarkers that can aid the early detection of pancreatic cancer using GC/MS/MS-based targeted metabolomics.
Hirata Y; Kobayashi T; Nishiumi S; Yamanaka K; Nakagawa T; Fujigaki S; Iemoto T; Kobayashi M; Okusaka T; Nakamori S; Shimahara M; Ueno T; Tsuchida A; Sata N; Ioka T; Yasunami Y; Kosuge T; Kaneda T; Kato T; Yagihara K; Fujita S; Yamada T; Honda K; Azuma T; Yoshida M
Clin Chim Acta; 2017 May; 468():98-104. PubMed ID: 28215548
[TBL] [Abstract][Full Text] [Related]
14. New strategies for the early detection of pancreatic cancer.
Petrone MC; Arcidiacono PG
Expert Rev Gastroenterol Hepatol; 2016; 10(2):157-9. PubMed ID: 26582179
[TBL] [Abstract][Full Text] [Related]
15. Metastatic pancreatic cancer: Mechanisms and detection (Review).
Chen X; Liu F; Xue Q; Weng X; Xu F
Oncol Rep; 2021 Nov; 46(5):. PubMed ID: 34498718
[TBL] [Abstract][Full Text] [Related]
16. Validation of Biomarkers for Early Detection of Pancreatic Cancer: Summary of The Alliance of Pancreatic Cancer Consortia for Biomarkers for Early Detection Workshop.
Young MR; Wagner PD; Ghosh S; Rinaudo JA; Baker SG; Zaret KS; Goggins M; Srivastava S
Pancreas; 2018 Feb; 47(2):135-141. PubMed ID: 29346214
[TBL] [Abstract][Full Text] [Related]
17. Risk factors, biomarker and imaging techniques used for pancreatic cancer screening.
Thomas C
Chin Clin Oncol; 2017 Dec; 6(6):61. PubMed ID: 29307201
[TBL] [Abstract][Full Text] [Related]
18. Early detection of sporadic pancreatic cancer: strategic map for innovation--a white paper.
Kenner BJ; Chari ST; Cleeter DF; Go VL
Pancreas; 2015 Jul; 44(5):686-92. PubMed ID: 25938853
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic strategies for early pancreatic cancer.
Hanada K; Okazaki A; Hirano N; Izumi Y; Teraoka Y; Ikemoto J; Kanemitsu K; Hino F; Fukuda T; Yonehara S
J Gastroenterol; 2015 Feb; 50(2):147-54. PubMed ID: 25501287
[TBL] [Abstract][Full Text] [Related]
20. Screening for pancreatic cancer: why, how, and who?
Poruk KE; Firpo MA; Adler DG; Mulvihill SJ
Ann Surg; 2013 Jan; 257(1):17-26. PubMed ID: 22895395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
